CONRAD DIAS
Ranchi, Nov 16: Global Health, the operator of the Medanta Hospital in Ranchi, saw 19 per cent growth on debut, listing at Rs 398.15 per share on the BSE and Rs 401 on the NSE.
Notably, the IPO was subscribed 9.58 times during November 3-7. Retail investors bid for 88 per cent of the allotted quota whereas non-institutional investors bought it 4.02 times, while QIBs booked theirs 28.64 times.
The company is involved in orthopaedics, neurosciences, oncology, digestive and hepatobiliary sciences, renal and urology, as well as cardiology and cardiac science. By bed capacity and operating revenues in FY22, it was one of the largest private multi-speciality tertiary care providers. It has branches in Patna, Ranchi, Lucknow, Gurugram, and Indore.
The company generated sales of Rs 2,166 crore during FY22 as opposed to Rs 1,418 crore in the prior fiscal. Revenue was Rs 596 crore for the three months that ended in June 2022 as opposed to Rs 472 crore in the prior year.
Accordingly, patient volumes, bed occupancy, and average revenue per occupied bed all increased, resulting in 50% growth in FY22 and 27% growth in the first quarter of FY23.
Over the past two years, the company’s EBIDTA margins have steadily increased, driven by higher margins at mature hospitals (which account for 85% of revenue), which were at 22.8 per cent in FY22, while EBIDTA margins at new hospitals (which account for 15% of revenue) increased to 20%.
